omniture

Chinese GAP Standard and Sichuan DAR Industry

Voice Diary Inc.
2007-05-07 14:58 1388

SUINING, China, May 7 /Xinhua-PRNewswire/ -- GAP for traditional Chinese medicine is a standard issued by SFDA (State Food And Drug Administration) to research, develop, grow and manage traditional Chinese medicines that are applying for internationally acclaimed standard. GAP for traditional Chinese medicine aims to control the quality of traditional Chinese medicine, to tackle issues such as "overproof of heavy metals", "chemical residues" and "overproof of microbe". Early in August, 1998, the European Community first initiated GAP, which was a new standard for the growing and processing of medicinal plants in order to ensure product quality. Later on, Japan and several countries in Northeast Asia followed EU's steps and acquired their own GAP.

On September 19, 2003, SFDA officially issued Regulation on Traditional Chinese Medicine Quality Control (GAP) and Evaluation Standards of GAP Certified Chinese Medicine, which took effect on November 1, 2003. Until most recently, only 46 traditional Chinese medicines have this national GAP certification. "Sichuan DAR GAP", owned by Suining Yinfa DAR Industrial Co., Ltd. (DAR Industrial), a subsidiary of Voice Diary Inc. (OTC Bulletin Board: VCDY), is one of the 46 to have the certification. The certification has been listed on the official website of SFDA since February 26, 2006.

DAR Industrial initiated the Chinese GAP for Sichuan DAR, which also conforms to international GAP standards of EU, North America and several East Asian regions and countries. All products of the Sichuan DAR from DAR Industrial have not exceeded the required level of heavy metals or any chemical residues. Sichuan DAR is widely used in Chinese medication, 760 out of the total 3000+ Chinese prescriptions contain Sichuan DAR. In order to pass the drug testing nationally and internationally, the drug has to use GAP certified Sichuan DAR from DAR Industrial. DAR Industrial has also developed pills and health food using Sichuan DAR as the main ingredient, those have been approved by SFDA include, Baining Tablet, which can cure headache, migraine, vascular headache and nervous debility; Yinshen Tablet, which is good for recovering from fatigue.

Many public companies in China made tremendous success after getting a GAP certification, including Beijing Tong Ren Tang Company with Ginseng GAP, Codonopsis Pilosulae GAP, Indigowoad Root GAP (ticker 600085, market value is approx. USD1.7 billion); Tianjin Tian Shi Li Company with Dan-Shen Root GAP (approx. USD1.1 billion market value, ticket 600535); Yunnan Bai Yao Company with Notoginseng GAP (approx. USD 1.9 billion market value, ticket 000538); San Jiu Pharmaceutical Company with Ophiopogonis GAP (approx. USD2 billion market value, ticket 000999), etc. Most of these companies export products to Europe and America.

The Chinese government is now trying to modernize the traditional Chinese medicine so as to open the international market. In this case, GAP will be a crucial factor. In the Government Work Report on March 2007 during the National People's Congress, Chinese Premier Wen, Jia Bao announced that "Support for the development of traditional Chinese medicine" was among the top priorities of the Chinese government in the coming years. The government will make a few policies to support the industry of traditional Chinese medicine in the following years.

About the Company

Suining Yinfa DAR Industrial Co., Ltd. (DAR Industrial), a subsidiary of Voice Diary Inc. (VCDY), was incorporated on April 24, 2001. It is one of China's leading industrialized agricultural corporations. DAR Industrial has focused on the production and further processing of Dahurian Angelica Root (DAR), an herb that is widely used in China, and considered to be an important ingredient Chinese traditional medicine. DAR Industrial's business plan includes distributing DAR and its related products to exploit a large market demand in the areas of treatment of pain, swelling and pustule.

Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such proclamations about future expectations, including future revenues and earnings and all other forward-looking statements be subject to the safe harbors created thereby. Voice Diary, Inc. depends on outside resources to maintain its continuation. Since these statements involve risks and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.

Source: Voice Diary Inc.
Keywords: Machinery
collection